ANDA 91206, held by Pliva Hrvatska Doo. Bivalirudin.
As of Nov 16, 2026, ANDA 91206 (Bivalirudin), held by Pliva Hrvatska Doo, was not approved, with 0 approved supplements and 0 published complete response letters.
| Date | Submission | Status | Documents |
|---|---|---|---|
| Sep 14, 2016 | Original application | Tentative approval | None posted |
| Product | Active ingredient | Marketing |
|---|---|---|
| Bivalirudin250MG/VIAL ยท injectable;intravenous | Bivalirudin | None (tentative approval) |
Approvals, supplements, products and documents come from FDA's Drugs@FDA data files, refreshed daily; Drugs@FDA lists approved applications only. Complete response letters are FDA's published letters. Drugs@FDA and FDA complete response letters